PROCARE INDUSTRIES LTD
10QSB, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: PROCARE INDUSTRIES LTD, 10QSB, 2000-11-14
Next: REPUBLIC SECURITY FINANCIAL CORP, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                            41
<SECURITIES>                                       0
<RECEIVABLES>                                      0
<ALLOWANCES>                                       0
<INVENTORY>                                        0
<CURRENT-ASSETS>                                  41
<PP&E>                                             0
<DEPRECIATION>                                     0
<TOTAL-ASSETS>                                     0
<CURRENT-LIABILITIES>                         25,476
<BONDS>                                            0
                              0
                                        0
<COMMON>                                   2,785,599
<OTHER-SE>                                         0
<TOTAL-LIABILITY-AND-EQUITY>                       0
<SALES>                                            0
<TOTAL-REVENUES>                              75,000
<CGS>                                              0
<TOTAL-COSTS>                                      0
<OTHER-EXPENSES>                              71,599
<LOSS-PROVISION>                                   0
<INTEREST-EXPENSE>                                 0
<INCOME-PRETAX>                                    0
<INCOME-TAX>                                       0
<INCOME-CONTINUING>                                0
<DISCONTINUED>                                     0
<EXTRAORDINARY>                                    0
<CHANGES>                                      3,402
<NET-INCOME>                                  38,201
<EPS-BASIC>                                        0
<EPS-DILUTED>                                      0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission